152 related articles for article (PubMed ID: 30054824)
1. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
[TBL] [Abstract][Full Text] [Related]
2. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
[TBL] [Abstract][Full Text] [Related]
3. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
[TBL] [Abstract][Full Text] [Related]
4. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
5. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
6. Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival.
Keck KJ; Choi A; Maxwell JE; Li G; O'Dorisio TM; Breheny P; Bellizzi AM; Howe JR
Ann Surg Oncol; 2017 Aug; 24(8):2206-2212. PubMed ID: 28560597
[TBL] [Abstract][Full Text] [Related]
7. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
Scheerer F; Schmitt W
Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.
Gay-Chevallier S; de Mestier L; Perinel J; Forestier J; Hervieu V; Ruszniewski P; Millot I; Valette PJ; Pioche M; Lombard-Bohas C; Subtil F; Adham M; Walter T
Neuroendocrinology; 2021; 111(8):718-727. PubMed ID: 32335556
[TBL] [Abstract][Full Text] [Related]
11. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
12. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.
Thang SP; Lung MS; Kong G; Hofman MS; Callahan J; Michael M; Hicks RJ
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):262-277. PubMed ID: 28894897
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
15. Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database.
Fairweather M; Swanson R; Wang J; Brais LK; Dutton T; Kulke MH; Clancy TE
Ann Surg Oncol; 2017 Aug; 24(8):2319-2325. PubMed ID: 28303430
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
17. Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis.
Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Bertani E; Guerini-Rocco E; Spada F; Orsi F
Cardiovasc Intervent Radiol; 2016 Jun; 39(6):948-52. PubMed ID: 26714693
[TBL] [Abstract][Full Text] [Related]
18. Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
Bertani E; Fazio N; Radice D; Zardini C; Grana C; Bodei L; Funicelli L; Ferrari C; Spada F; Partelli S; Falconi M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):981-989. PubMed ID: 27613553
[TBL] [Abstract][Full Text] [Related]
19. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
20. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
